IGF1 and non-Hodgkin lymphoma: Overall, we are unaware of any studies of the insulin/IGF axis and its role in NHL or MM development that have adequately addressed concerns regarding the use of non-fasting blood specimens, inclusion of type 2 diabetics (or pre-diabetics using diabetic medication) or inclusion of postmenopausal women using HT.